Osimertinib Mesylate
Stock Recap #PipelineProspector

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Pharma indices settled slightly lower in September after four months of solid gains. The three major

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

As summer draws to a close, pharma and biotech indices posted their fourth consecutive month in the

Pipeline Prospector Feb 2023: Low demand for Covid drugs hammers down Lilly, Moderna stocks

The year had opened on a buoyant note. But February quickly dashed any hopes of a market rebound and